Epilepsy Research
Volume 25, Issue 1 , Pages 11-19 , September 1996

Thalamic NMDA transmission in a genetic model of absence epilepsy in rats

Received 18 November 1995 ,Revised 14 February 1996 ,Accepted 27 February 1996.

References 

  1. Ascher P, Johnson JW. The NMDA receptor, its channel, and its modulation by glycine. In:  Watkins JC,  Collingridge GL editor. The NMDA Receptor. Oxford: Oxford University Press; 1989;p. 109–122
  2. Avanzini G, De Curtis M, Marescaux C, Panzica F, Spraefico R, Vergnes M. Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves. In:  Marescaux C,  Vergnes M,  Bernasconi R editor. Generalized Non-Convulsive Epilepsy: Focus on GABA-B Receptors. J. Neural Transm., Suppl. 35. Vienna: Springer; 1992;p. 85–95
  3. Avoli M, Gloor P. Interaction of cortex and thalamus in spike and wave discharges of feline generalized penicillin epilepsy. Exp. Neurol. 1982;76:196–217
  4. Bal T, McCormick DA. Mechanisms of oscillatory activity in guinea pig nucleus reticularis thalami in vitro: a mammalian pacemaker. J. Physiol. (Lond.). 1993;468:669–691
  5. Banerjee PK, Snead OC. Excitatory amino acid-mediated mechanisms in the γ-hydroxybutyrate model of absence. Neuropharmacology. 1992;31:1009–1019
  6. Banerjee PK, Snead OC. Thalamic NMDA receptors in the gamma-hydroxybutyrate model of absence seizures: a cerebral microinjection study in rats. Neuropharmacology. 1995;34:43–53
  7. Birch PJ, Grossman CJ, Hayes AG. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur. J. Pharmacol. 1988;154:85–88
  8. Buzaki G. The thalamic clock: emergent network properties. Neuroscience. 1991;41:351–364
  9. Coenen AML, Drinkenburg WHIM, Peeters BWMM, Vossen JMH, Van Luijtelaar ELTM. Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. Neurosci. Biobehav. Rev. 1991;15:259–263
  10. Crunelli V, Leresche N. A role for GABA-B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 1991;14:16–21
  11. Danober L, Depaulis A, Marescaux C, Vergnes M. Effects of cholinergic drugs on genetic absence seizures in rats. Eur. J. Pharmacol. 1993;234:263–268
  12. Frey HH, Voits M. Effect of psychotropic agents on a model of absence epilepsy in rats. Neuropharmacology. 1991;30:651–656
  13. Fujikawa DG, Daniels AH, Kim JS. The competitive NMDA receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res. 1994;17:207–219
  14. Inoue M, Duysens J, Vossen JMH, Coenen AML. Thalamic multiple-unit activity underlying spike-wave discharges in anesthetized rats. Brain Res. 1993;612:35–40
  15. Iversen LL, Woodruff GN, Kemp JA, Foster AC, McKernan R, Gill R, et al. Non-competitive NMDA antagonists as drugs. In:  Watkins JC,  Collingridge GL editor. The NMDA Receptor. Oxford: Oxford University Press; 1989;p. 217–225
  16. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987;325:529–531
  17. Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science. 1988;241:835–837
  18. Lannes B, Micheletti G, Vergnes M, Marescaux C, Depaulis A, Warter JM. Relationship between spike-wave discharges and vigilance levels in rats with spontaneous petit mal-like epilepsy. Neurosci. Lett. 1988;94:187–191
  19. Liu Z, Vergnes M, Depaulis A, Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res. 1991;545:1–7
  20. Lodge D, Jones M, Fletcher E. Non-competitive antagonists of N-methyl-d-aspartate. In:  Watkins JC,  Collingridge GL editor. The NMDA Receptor. Oxford: Oxford University Press; 1989;p. 37–51
  21. Marescaux C, Vergnes M, Depaulis A. Genetic absence epilepsy in rats from Strasbourg. A review. J. Neural Transm. 1992;(Suppl. 35):37–69
  22. Marescaux C, Vergnes M, Bernasconi R. GABAB receptor antagonists: potential new anti-absence drugs. J. Neural Transm. 1992;(Suppl. 35):179–188
  23. Marescaux C, Vergnes M, Depaulis A. Neurotransmission in rats' spontaneous generalized nonconvulsive epilepsy. In:  Avanzini G,  Engel J,  Fariello R,  Heinemann U editor. Neurotransmitters in Epilepsy (Epilepsy Res. Suppl. 8). Amsterdam: Elsevier Science; 1992;p. 335–343
  24. McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamo-cortical activity. Prog. Neurobiol. 1992;39:337–388
  25. McCormick DA, Von Krosigk M. Corticothalamic activation modulates thalamic firing through activation of glutamate metabotropic receptors. In: Proc. Natl. Acad. Sci. USA. 89:1992;p. 2774–2778
  26. McLachlan RS, Avoli M, Gloor P. Transition from spindles to generalized spike and wave discharges in the cat: simultaneous single-cell recordings in cortex and thalamus. Exp. Neurol. 1984;85:413–425
  27. Meldrum BS, Chapman AG, Patel S, Swan J. Competitive NMDA antagonists as drugs. In:  Watkins JC,  Collingridge GL editor. The NMDA Receptor. Oxford: Oxford University Press; 1989;p. 207–216
  28. Meldrum BS. Excitatory amino acid neurotransmission in epilepsy and anticonvulsant therapy. In:  Meldrum BS editors. Excitatory Amino Acids. New York: Raven Press; 1991;p. 655–670
  29. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology. 1994;44(Suppl. 8):S14–S23
  30. Moore KW, Leeson PD, Carling RW, Tricklebank MD, Singh L. Anticonvulsant activity of glycine-site NMDA antagonists. 1. 2-Carboxyl products of 5,7-dichlorokynurenic acid. Bioorg. Med. Chem. Lett. 1993;3:61–64
  31. Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. Sydney: Academic Press; 1986;
  32. Peeters BWMM, Van Rijn CM, Van Luijtelaar ELJM, Coenen AML. Antiepileptic and behavioural actions of MK-801 in an animal model of spontaneous absence epilepsy. Epilepsy Res. 1989;3:178–181
  33. Peeters BWMM, Van Rijn CM, Vossen JMH, Coenen AML. Involvement of NMDA receptors in nonconvulsive epilepsy in WAG/Rij rats. Life Sci. 1990;47:523–529
  34. Steriade M, Domich L, Oakson G. Reticularis thalami neurons revisited: activity changes during shifts in states of vigilance. J. Neurosci. 1986;6:68–81
  35. Steriade M, Llinás RR. The functional states of the thalamus and the associated neuronal interplay. Physiol. Rev. 1988;68:649–742
  36. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science. 1993;262:679–685
  37. Vergnes M, Marescaux C. Cortical and thalamic lesions in rats with genetic absence epilepsy. J. Neural Transm. 1992;(Suppl. 35):71–84
  38. Vergnes M, Marescaux C. Pathophysiological mechanisms underlying genetic absence epilepsy in rats. In:  Malafosse A,  Genton P,  Hirsch E,  Marescaux C,  Broglin D,  Bernasconi R editor. Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. London: John Libbey; 1994;p. 151–168
  39. Vergnes M, Marescaux C, Boehrer A, Depaulis A. Are rats with genetic absence epilepsy behaviourally impaired?. Epilepsy Res. 1991;9:97–104
  40. Vergnes M, Marescaux C, Depaudis A. Mapping of spontaneous spike and wave discharges in Wistar rats with genetic generalized non-convulsive epilepsy. Brain Res. 1990;523:87–91

PII: 0920-1211(96)00015-0

Epilepsy Research
Volume 25, Issue 1 , Pages 11-19 , September 1996

Article Tools